FDA Stops Export of Americans' Cells for Foreign Genetic Engineering Trials
TL;DR
The FDA has halted new clinical trials involving the export of Americans' cells to foreign countries for genetic engineering due to concerns over lack of participant consent and potential misuse of genetic data by foreign governments, especially in light of recent exemptions that allowed such exports despite security risks.
FDA halts new clinical trials that export Americans’ cells to foreign labs in hostile countries for genetic engineering National Institutes of Health (NIH) | (.gov)View Full Coverage on Google News
Want the full story? Read the original reporting
Read on National Institutes of Health (NIH) | (.gov)